Cargando…
High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases
Neurodegenerative diseases (NDDs) are incurable and debilitating conditions that result in progressive degeneration and/or death of nerve cells in the central nervous system (CNS). Identification of viable therapeutic targets and new treatments for CNS disorders and in particular, for NDDs is a majo...
Autores principales: | Aldewachi, Hasan, Al-Zidan, Radhwan N., Conner, Matthew T., Salman, Mootaz M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926814/ https://www.ncbi.nlm.nih.gov/pubmed/33672148 http://dx.doi.org/10.3390/bioengineering8020030 |
Ejemplares similares
-
Microfluidic High-Throughput Platforms for Discovery of Novel Materials
por: Zhou, Peipei, et al.
Publicado: (2020) -
Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery
por: LaBarbera, Kelsie Mozzoni, et al.
Publicado: (2021) -
Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases
por: Salman, Mootaz M., et al.
Publicado: (2021) -
Adaptation of High-Throughput Screening in Drug Discovery—Toxicological Screening Tests
por: Szymański, Paweł, et al.
Publicado: (2011) -
High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
por: Alonso-Padilla, Julio, et al.
Publicado: (2014)